The Funding beat on Biotech tracks 59 verified stories, with 3 clearing multi-source corroboration in the last 7 days at mean impact 5/10 — live SQLite counts, not editorial weighting.
9 stories
Beat pulse
Last 7 days · Funding
→
3stories
avg impact
0%positive
0%negative
vs prior 7 days-2-2 stories vs prior 7 days
Impact 5.0/10 (-0.4 vs prior). Counts are stories in our record, not a market forecast.
Stories appear on this page because our classification stage assigned them this category as their primary topic — each story receives exactly one category per niche, chosen from a fixed list, so a story that touches both a funding round and a product launch in the same week sorts into whichever category best matches its dominant subject, not both. This keeps each category page focused on one beat rather than a blend of unrelated developments, and applies the same source-verification standard used across every story on this site. Sentiment measures the directional read of each development for this category specifically, not the tone of the reporting, and impact weights how consequential a development is — regulatory, financial, or operational — rather than how widely it was syndicated across outlets.
Figures are computed live from our source-verified story record
(as of ) The volume change compares this window with the prior 7 days in the same record. — see our methodology for how impact and
sentiment are derived.
Beat actors
Who drives Funding
Entities appearing in at least two verified funding stories on this desk — ranked by mention count, not editorial preference.
The TED Audacious Project has successfully raised $1 billion in just two days to fund large-scale nonprofit initiatives. This massive capital influx is expected to drive significant advancements in global health, biotechnology, and environmental science through non-dilutive funding.
Oncology startup Oncare has raised ₹27 Crore ($3.2 million) in a Series A funding round led by Sky Impact Capital. The capital will drive the expansion of its specialized clinic network from Delhi NCR into Tier-2 and Tier-3 Indian markets to bridge the gap in cancer care accessibility.
Union Minister Jitendra Singh has positioned artificial intelligence as the central pillar of India's agricultural strategy, backed by a ₹10,372-crore sovereign investment. The initiative introduces 'Agri Param,' a domain-specific AI model supporting 22 languages to bridge the information gap for 600 million farmers.
Rakovina Therapeutics has announced an upsized financing package totaling up to $2.0 million, split between convertible debentures and a private placement. The capital injection is earmarked for near-term operations as the company advances its DNA-damage response (DDR) oncology programs.
Psyence Biomedical Ltd. (Nasdaq: PBM) has confirmed a strategic equity investment in PsyLabs following the exercise of a pre-existing put option agreement. The transaction reinforces the vertical integration between the clinical-stage developer and its primary source of pharmaceutical-grade, nature-derived psychedelic compounds.
Advocates, led by the American Heart Association, are calling on Michigan legislators to increase funding for school-based cardiac emergency programs. The initiative aims to provide every school with Automated External Defibrillators (AEDs) and comprehensive staff training to combat sudden cardiac arrest in students.
SpendRule has secured $2M in seed funding to launch its AI-powered platform designed to provide healthcare systems with real-time visibility into operational expenditures. The startup aims to eliminate 'dark spend' and administrative waste within the fragmented financial ecosystems of modern hospitals.
Wellgistics Health has executed a strategic investment in a stealth-mode mental health AI startup, signaling a major pivot toward high-margin digital health software. The move positions the company to capture a significant share of the $6.3 billion mental health software market through advanced artificial intelligence capabilities.
Sift Biosciences has secured $3.7 million in a pre-seed financing round co-led by Lifespan Vision Ventures to advance its innovative technology platform. The investment underscores a growing trend of early-stage capital flowing into biotech startups focused on longevity and age-related diseases.
According to our own tracking database, this category has accumulated 59 funding stories since coverage began. This page aggregates the latest funding stories within our biotech coverage area. Every story is cross-referenced across multiple primary sources, scored for sentiment and operational impact, and timestamped so fresh developments surface first. We track biotech venture funding, grants and surface the angles a domain expert would actually read.
Story selection follows our editorial methodology — impact scoring weights regulatory, financial, and operational developments distinctly. Sentiment is classified across five tiers via supervised classification trained on labeled industry corpora. See our glossary for term definitions and our trends index for longitudinal patterns across the biotech beat.
Stories only surface on this page once the classifier scores them at a minimum 35 percent
relevance to the category. According to that methodology, reviewed July 2026, this follows
multi-source corroboration standards recommended by journalism research bodies such as the
Reuters Institute for the Study of Journalism.
See something wrong on this page — a wrong stat, a broken source link, a miscategorized
story? Report a data issue.
Signal
What it tells you
Verified by N sources
Confidence the story isn't a single-source rumor — N≥2 means the development is independently corroborated.
Impact score (1-10)
Estimated regulatory, financial, or operational impact. 8+ indicates a story experienced operators should act on.
Sentiment
Five-tier classification (very bullish through very bearish) trained on labeled biotech-specific corpora.
Time stamp
Recency. Fresh stories (under 1h) render with a highlighted timestamp; stale stories (≥24h) render dimmed.